The control of homologous lysis
- PMID: 1721817
- DOI: 10.1016/0167-5699(91)90005-E
The control of homologous lysis
Abstract
Complement activation unleashes powerful effector mechanisms against which host cells are protected by homologous restriction factors. These factors are glycolipid-anchored membrane proteins that either induce C3 convertase dissociation (for example decay-accelerating factor) or prevent the full development of the membrane attack complex (for example homologous restriction factor and CD59). In this article Peter Lachmann explores the biology and biochemistry of these important and intriguing molecules.
Similar articles
-
Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.J Immunol. 1985 Jan;134(1):506-11. J Immunol. 1985. PMID: 3964820
-
Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.J Immunol. 1992 Jan 15;148(2):498-502. J Immunol. 1992. PMID: 1370313
-
Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.J Immunol. 1986 Mar 1;136(5):1777-82. J Immunol. 1986. PMID: 2419414
-
Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.Am J Med. 1989 Sep;87(3N):22N-29N. Am J Med. 1989. PMID: 2484793 Review.
-
CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex.Exp Clin Immunogenet. 1992;9(1):33-47. Exp Clin Immunogenet. 1992. PMID: 1379443 Review.
Cited by
-
Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma.Cancer Immunol Immunother. 2004 Feb;53(2):110-7. doi: 10.1007/s00262-003-0436-1. Epub 2003 Oct 16. Cancer Immunol Immunother. 2004. PMID: 14564483 Free PMC article. Clinical Trial.
-
C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.Infect Immun. 1994 Oct;62(10):4101-6. doi: 10.1128/iai.62.10.4101-4106.1994. Infect Immun. 1994. PMID: 7927662 Free PMC article.
-
Recombinant soluble CD59 inhibits reactive haemolysis with complement.Immunology. 1994 May;82(1):34-41. Immunology. 1994. PMID: 7519172 Free PMC article.
-
Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.Virchows Arch. 1995;426(6):603-10. doi: 10.1007/BF00192116. Virchows Arch. 1995. PMID: 7655742
-
Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.Virchows Arch. 1997 Apr;430(4):327-32. doi: 10.1007/BF01092756. Virchows Arch. 1997. PMID: 9134044
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous